Clinical Trial Update: Low-Dose Danazol for the Treatment of Telomere Related Diseases [Phase 2]

View source ↗

Summary

This update reports a Phase 2 clinical trial evaluating low-dose danazol for telomere biology disorders, with the study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Telomere Biology Disorders

Drugs mentioned

• Danazol (danazol)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Telomere Disease | Phase 2 | Status: RECRUITING